In Vitro Analysis of the Effects of ITER-Like Tungsten Nanoparticles: Cytotoxicity and Epigenotoxicity in BEAS-2B Cells.

BEAS-2B cells. DNA damage DNA methylation cytotoxicity epigenetics in vitro testing micronuclei formation nanoparticles tritiated particles tungsten

Journal

Nanomaterials (Basel, Switzerland)
ISSN: 2079-4991
Titre abrégé: Nanomaterials (Basel)
Pays: Switzerland
ID NLM: 101610216

Informations de publication

Date de publication:
30 Aug 2019
Historique:
received: 26 07 2019
revised: 22 08 2019
accepted: 26 08 2019
entrez: 5 9 2019
pubmed: 5 9 2019
medline: 5 9 2019
Statut: epublish

Résumé

Tungsten was chosen as a wall component to interact with the plasma generated by the International Thermonuclear Experimental fusion Reactor (ITER). Nevertheless, during plasma operation tritiated tungsten nanoparticles (W-NPs) will be formed and potentially released into the environment following a Loss-Of-Vacuum-Accident, causing occupational or accidental exposure. We therefore investigated, in the bronchial human-derived BEAS-2B cell line, the cytotoxic and epigenotoxic effects of two types of ITER-like W-NPs (plasma sputtering or laser ablation), in their pristine, hydrogenated, and tritiated forms. Long exposures (24 h) induced significant cytotoxicity, especially for the hydrogenated ones. Plasma W-NPs impaired cytostasis more severely than the laser ones and both types and forms of W-NPs induced significant micronuclei formation, as shown by cytokinesis-block micronucleus assay. Single DNA strand breaks, potentially triggered by oxidative stress, occurred upon exposure to W-NPs and independently of their form, as observed by alkaline comet assay. After 24 h it was shown that more than 50% of W was dissolved via oxidative dissolution. Overall, our results indicate that W-NPs can affect the in vitro viability of BEAS-2B cells and induce epigenotoxic alterations. We could not observe significant differences between plasma and laser W-NPs so their toxicity might not be triggered by the synthesis method.

Identifiants

pubmed: 31480309
pii: nano9091233
doi: 10.3390/nano9091233
pmc: PMC6780084
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : A*MIDEX
ID : ANR-11-IDEX-0001-02

Références

Chem Res Toxicol. 1995 Jun;8(4):600-6
pubmed: 7548741
Int J Nanomedicine. 2011;6:167-78
pubmed: 21499416
J Appl Toxicol. 2018 Jun;38(6):896-913
pubmed: 29405315
Mol Carcinog. 2017 Jul;56(7):1778-1788
pubmed: 28218462
Toxicol Appl Pharmacol. 2011 Jun 15;253(3):178-87
pubmed: 21513724
Toxicol Sci. 2015 Feb;143(2):385-97
pubmed: 25398624
Mutagenesis. 2011 Jan;26(1):185-91
pubmed: 21164201
IARC Monogr Eval Carcinog Risks Hum. 2006;86:1-294
pubmed: 16906675
Sci Total Environ. 1997 Nov 5;206(2-3):147-65
pubmed: 9394480
Environ Health Perspect. 2009 Apr;117(4):530-6
pubmed: 19440490
Toxicol Appl Pharmacol. 2015 Oct 1;288(1):33-9
pubmed: 26164860
J Immunotoxicol. 2010 Jul-Sep;7(3):174-82
pubmed: 20178456
Toxicol Appl Pharmacol. 2014 Jul 1;278(1):1-8
pubmed: 24746988
Toxicol Sci. 2014 Jan;137(1):125-34
pubmed: 24085191
Part Fibre Toxicol. 2016 Feb 03;13:5
pubmed: 26843362
Pharm Sci Technolo Today. 2000 Jan;3(1):18-27
pubmed: 10637597
Nucleic Acids Res. 2019 Apr 8;47(6):2822-2839
pubmed: 30698748
Drug Metab Dispos. 2012 Oct;40(10):1953-65
pubmed: 22798553
Nat Protoc. 2007;2(5):1084-104
pubmed: 17546000

Auteurs

Chiara Uboldi (C)

CNRS, IRD, IMBE, Avignon Université, Aix Marseille Université, 13005 Marseille, France.

Marcos Sanles Sobrido (M)

CNRS, IRD, INRA, Coll France, CEREGE, Aix Marseille Université, 13545 Aix-en-Provence, France.

Elodie Bernard (E)

CNRS, LP3, Aix Marseille Université, 13005 Marseille, France.
CEA, CNRS, BIAM, Aix Marseille Université, 13108 Saint Paul-Lez-Durance, France.

Virginie Tassistro (V)

CNRS, IRD, IMBE, Avignon Université, Aix Marseille Université, 13005 Marseille, France.

Nathalie Herlin-Boime (N)

CEA, IRAMIS UMR NIMBE, Université Paris Saclay, 91191 Gif-sur-Yvette, France.

Dominique Vrel (D)

LSPM, Université Paris 13, UPR 3407 CNRS, 93430 Villetaneuse, France.

Sébastien Garcia-Argote (S)

CEA, SCBM, Université Paris Saclay, 91191 Gif-sur-Yvette, France.

Stéphane Roche (S)

INSERM, MMG, Aix Marseille Université, 13005 Marseille, France.

Fréderique Magdinier (F)

INSERM, MMG, Aix Marseille Université, 13005 Marseille, France.

Gheorghe Dinescu (G)

INFLPR, 409 Atomistilor Street, Magurele, 77125 Bucharest, Romania.

Véronique Malard (V)

CEA, CNRS, BIAM, Aix Marseille Université, 13108 Saint Paul-Lez-Durance, France.

Laurence Lebaron-Jacobs (L)

CEA, CNRS, BIAM, Aix Marseille Université, 13108 Saint Paul-Lez-Durance, France.

Jerome Rose (J)

CNRS, IRD, INRA, Coll France, CEREGE, Aix Marseille Université, 13545 Aix-en-Provence, France.

Bernard Rousseau (B)

CEA, SCBM, Université Paris Saclay, 91191 Gif-sur-Yvette, France.

Philippe Delaporte (P)

CNRS, LP3, Aix Marseille Université, 13005 Marseille, France.

Christian Grisolia (C)

CEA, IRFM, 13108 Saint Paul lez Durance, France.

Thierry Orsière (T)

CNRS, IRD, IMBE, Avignon Université, Aix Marseille Université, 13005 Marseille, France. thierry.orsiere@imbe.fr.

Classifications MeSH